A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence
Study Identifier
191622-125
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
18+ years
Protocol Summary
A study to evaluate the efficacy and safety of BOTOX® or Solifenacin in patients with overactive bladder (OAB) and urinary incontinence.
Study Locations
Location
Status
Location
Newport Beach, California, United States
Status
Not applicable
Location
Leuven, Belgium
Status
Not applicable
Location
Vancouver, British Columbia, Canada
Status
Not applicable
Location
Toronto, Ontario, Canada
Status
Not applicable
Location
Prague, Czech Republic
Status
Not applicable
Location
Berlin, Germany
Status
Not applicable
Showing {first} - {last} of {total} Results